Recruiting

Observational Study

Sponsor:

University of Chicago

Code:

NCT05264051

Conditions

Liver Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in patients with liver disease.

Conditions

Liver Diseases

Study ID

NCT05264051

Start date

Apr 18, 2022

Status verified date

Jan, 2026

Completion date

Mar 1, 2027

Anticipated

Primary completion date

Mar 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated

Exclusion Criteria:

  • <18 yrs. of age

Study Design

Enrollment

1200 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Waitlist Mortality [ Time Frame: Measured up to 10 years out from enrollment ]

Central Contacts and Locations

Central contacts

Omar Jamil, MD

847-373-2360Omar.Jamil@uchospitals.edu

Maria Newsome

773-702-2788mnewsome1@bsd.uchicago.edu

Locations

The University of Chicago

Recruiting

Chicago, Illinois, United States, 60637

Contacts

Maria Newsome

773-702-2788mnewsome1@bsd.uchicago.edu

Omar Jamal, MD

773-702-0309Omar.Jamil@uchospitals.edu

Principal Investigator:

Michael Charlton, MD

More Information

Sponsor

University of Chicago

Last update posted

Jan 14, 2026

Last verified

Jan, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Chicago on 2026-01-14.